Targeting janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution

U Bharadwaj, MM Kasembeli, P Robinson… - Pharmacological …, 2020 - Elsevier
Before it was molecularly cloned in 1994, acute-phase response factor or signal transducer
and activator of transcription (STAT) 3 was the focus of intense research into understanding …

[HTML][HTML] Regulation of the iron homeostatic hormone hepcidin

V Sangkhae, E Nemeth - Advances in nutrition, 2017 - Elsevier
Iron is required for many biological processes but is also toxic in excess; thus, body iron
balance is maintained through sophisticated regulatory mechanisms. The lack of a regulated …

Discovery and development of Janus Kinase (JAK) inhibitors for inflammatory diseases: Miniperspective

JD Clark, ME Flanagan, JB Telliez - Journal of medicinal chemistry, 2014 - ACS Publications
The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential
role in the signaling of numerous cytokines that have been implicated in the pathogenesis of …

Immunomodulatory functions of type I interferons

JM González-Navajas, J Lee, M David… - Nature Reviews …, 2012 - nature.com
Interferon-α (IFNα) and IFNβ, collectively known as type I IFNs, are the major effector
cytokines of the host immune response against viral infections. However, the production of …

Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and subsequent behavior at 2 years of age

AM Graham, JM Rasmussen, MD Rudolph, CM Heim… - Biological …, 2018 - Elsevier
Background Maternal inflammation during pregnancy increases the risk for offspring
psychiatric disorders and other adverse long-term health outcomes. The influence of …

Targeting TGF-β signaling for the treatment of fibrosis

AH Györfi, AE Matei, JHW Distler - Matrix biology, 2018 - Elsevier
Transforming growth factor-β (TGF-β) is widely recognized as a core pathway of fibrosis.
Inhibition of TGF-β signaling may thus offer potential for antifibrotic therapies. Long-term …

JAK inhibitors for treatment of psoriasis: focus on selective TYK2 inhibitors

M Nogueira, L Puig, T Torres - Drugs, 2020 - Springer
Despite advances in the treatment of psoriasis, there is an unmet need for effective and safe
oral treatments. The Janus Kinase–Signal Transducer and Activator of Transcription (JAK …

[HTML][HTML] The regulation of JAKs in cytokine signaling and its breakdown in disease

HM Hammarén, AT Virtanen, J Raivola, O Silvennoinen - Cytokine, 2019 - Elsevier
The JAK–STAT signal transduction pathway is responsible for mediating signals of over fifty
cytokines, growth factors and hormones. Signaling through the JAK–STAT pathway is …

Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)

K Ghoreschi, MI Jesson, X Li, JL Lee… - The Journal of …, 2011 - journals.aai.org
Inhibitors of the JAK family of nonreceptor tyrosine kinases have demonstrated clinical
efficacy in rheumatoid arthritis and other inflammatory disorders; however, the precise …

Function of mitochondrial Stat3 in cellular respiration

J Wegrzyn, R Potla, YJ Chwae, NBV Sepuri, Q Zhang… - Science, 2009 - science.org
Cytokines such as interleukin-6 induce tyrosine and serine phosphorylation of Stat3 that
results in activation of Stat3-responsive genes. We provide evidence that Stat3 is present in …